Long-term Safety and Efficacy of Esketamine Nasal Spray Plus an Oral Antidepressant in Patients with Treatment-resistant Depression– an Asian Sub-group Analysis from the SUSTAIN-2 Study

OBJECTIVE: To evaluate the long-term safety and efficacy of intranasal esketamine in patients with treatment-resistant depression from the Asian subgroup of the SUSTAIN-2 study. METHODS: SUSTAIN-2 was a phase 3, open-label, single-arm, multicenter study comprising a 4-week screening, 4-week inductio...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeon, Hong Jin, Ju, Po-Chung, Sulaiman, Ahmad Hatim, Aziz, Salina Abdul, Paik, Jong-Woo, Tan, Wilson, Bai, Daisy, Li, Cheng-Ta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean College of Neuropsychopharmacology 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813327/
https://www.ncbi.nlm.nih.gov/pubmed/35078950
http://dx.doi.org/10.9758/cpn.2022.20.1.70

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813327/
https://www.ncbi.nlm.nih.gov/pubmed/35078950
http://dx.doi.org/10.9758/cpn.2022.20.1.70

Ejemplares similares